ArticleResearch square2026
Digital quantification of vascular β-amyloid and perivascular plaques in cerebral amyloid angiopathy.
Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Introduction: This study aimed to 1) develop a quantitative approach to automate detection of cortical CAA-positive vessels separate from β-amyloid plaques, 2) validate digital pathology classifier for CAA against manual scoring, and 3) characterize the spatial distribution of perivascular β-amyloid plaques in relation to CAA-positive vessels. Methods: Digital pathology classifiers were trained on the HALO AI platform to distinguish cortical CAA-positive vessels from β-amyloid plaques in the calcarine cortex. Classifiers were applied to digitized histopathologic slides (n = 100), previously rated by expert neuropathologists. Slide level digital quantitative measures for CAA (CAA classified area and vascular β-amyloid percent positivity) and for β-amyloid plaques (β-amyloid plaque classified area) were compared with manual CAA scores and Alzheimer's disease neuropathologic change (ADNC). Perivascular plaques, defined as β-amyloid plaques within a 0- to 150-micron concentric distance from the center of CAA-positive vessels, were identified. Results: Participants had a mean age of 91.1 (SD = 5.6) years at death, with 76% being women. Digital pathology quantification for CAA classified area and vascular β-amyloid percent positivity showed strong correlations with semi-quantitative manual CAA scores (r Conclusion: Digital pathology classifiers reliably distinguish cortical CAA vessels from β-amyloid plaques and can be utilized to study plaque proximity to CAA-positive vessels severity, supporting the use of digital pathology to advance understanding of CAA pathogenesis.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.